Dr. Lio discusses his clinical experience using topical ruxolitinib for patients with atopic dermatitis and how this therapy supports more sustainable disease control. He shares insights on integrating targeted topical treatments into individualized care plans to improve symptom relief and long-term outcomes.
Topics Covered:
Explore Related Resources:
